DK534188D0 - Hidtil ukendt vaccine - Google Patents

Hidtil ukendt vaccine

Info

Publication number
DK534188D0
DK534188D0 DK534188A DK534188A DK534188D0 DK 534188 D0 DK534188 D0 DK 534188D0 DK 534188 A DK534188 A DK 534188A DK 534188 A DK534188 A DK 534188A DK 534188 D0 DK534188 D0 DK 534188D0
Authority
DK
Denmark
Prior art keywords
compositions
vaccine
unknown
inactivating
prophylaxis
Prior art date
Application number
DK534188A
Other languages
English (en)
Other versions
DK175379B1 (da
DK534188A (da
Inventor
Dale Bordt
Hans Draayer
Original Assignee
Beecham Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Inc filed Critical Beecham Inc
Publication of DK534188D0 publication Critical patent/DK534188D0/da
Publication of DK534188A publication Critical patent/DK534188A/da
Application granted granted Critical
Publication of DK175379B1 publication Critical patent/DK175379B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/215Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225Porcine transmissible gastroenteritis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/245Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265Infectious rhinotracheitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20061Methods of inactivation or attenuation
    • C12N2770/20063Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DK198805341A 1987-09-28 1988-09-26 Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine DK175379B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10182287A 1987-09-28 1987-09-28
US10182287 1987-09-28

Publications (3)

Publication Number Publication Date
DK534188D0 true DK534188D0 (da) 1988-09-26
DK534188A DK534188A (da) 1989-03-29
DK175379B1 DK175379B1 (da) 2004-09-20

Family

ID=22286587

Family Applications (2)

Application Number Title Priority Date Filing Date
DK198805341A DK175379B1 (da) 1987-09-28 1988-09-26 Anvendelse af transmitterbart svine-gastro-enteritisvirus samt fremgangsmåde til fremstilling af en vaccine
DK198805342A DK175308B1 (da) 1987-09-28 1988-09-26 En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK198805342A DK175308B1 (da) 1987-09-28 1988-09-26 En vaccinekomposition omfattende et inaktiveret virus eller bakterium, fremgangsmåde til fremstilling deraf samt anvendelsen af en substans eller en komposition i fremstillingen deraf

Country Status (14)

Country Link
EP (2) EP0310317B1 (da)
JP (2) JP2715114B2 (da)
KR (2) KR0135426B1 (da)
AT (2) ATE98680T1 (da)
AU (2) AU624081B2 (da)
CA (2) CA1331562C (da)
DE (2) DE3886332T2 (da)
DK (2) DK175379B1 (da)
ES (2) ES2061673T3 (da)
GR (1) GR3015608T3 (da)
IE (2) IE66015B1 (da)
NZ (2) NZ226332A (da)
PT (2) PT88591B (da)
ZA (2) ZA887196B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE66015B1 (en) * 1987-09-28 1995-11-29 Beecham Inc TGEV-virus of swine as a dog vaccine
ATE124421T1 (de) * 1989-09-25 1995-07-15 Genetics Inst Verfahren zur wachstumshemmung von stammzellen.
US5276142A (en) * 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
DE69116606T2 (de) * 1990-06-07 1996-05-30 Bayer Ag Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
JPH0813753B2 (ja) * 1992-05-22 1996-02-14 株式会社微生物化学研究所 牛伝染性鼻気管炎ウイルス感染症、牛ウイルス性下痢−粘膜病ウイルス感染症、パラインフルエンザ3型ウイルス感染症、牛rsウイルス感染症および牛アデノ7型ウイルス感染症5種混合生ワクチン
AU5321094A (en) * 1992-10-05 1994-04-26 Rhone Merieux, Inc High potency vaccines
JP2521226B2 (ja) * 1993-01-28 1996-08-07 株式会社微生物化学研究所 犬用多種混合ワクチン
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
EP0612532A3 (en) * 1993-02-26 1998-02-04 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
US5362442A (en) 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
AU677090B2 (en) * 1993-08-06 1997-04-10 Connaught Laboratories Limited Inactivated respiratory syncytial viral vaccines
CA2184132C (en) 1995-09-21 2011-03-15 Kristina J. Hennessy An adjuvanted vaccine which is substantially free of non-host albumin
US6682746B2 (en) 1995-09-21 2004-01-27 Kristina J. Hennessy Adjuvanted vaccine which is substantially free of non-host albumin
US5853715A (en) * 1996-08-16 1998-12-29 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
EP0978286A1 (en) * 1998-08-07 2000-02-09 Bayer Corporation Cross-protective equine herpesvirus preparations and method of making and using the same
US6682695B2 (en) 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
US6696060B2 (en) 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US7252799B2 (en) 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
US20030095890A1 (en) 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US6908591B2 (en) 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN103709248B (zh) * 2013-12-24 2019-07-16 北京大北农科技集团股份有限公司动物医学研究中心 一种抗猪传染性胃肠炎病毒高免血清及其制备方法
DE202020001666U1 (de) 2020-04-21 2020-06-08 Walther Enßlin Imprägnierung der Oberfläche von Kleidung, Schutzkleidung, Gewebehandschuhen gegen Viren aus den Tröpfchen der Atemluft
DE202020003865U1 (de) 2020-09-11 2021-09-22 Karin Emde Einfangen und Vernichten von Viren und andere Mikroorganismen in Raumluft und Raumluftfiltern
DE102021001635A1 (de) 2021-03-27 2022-09-29 Karin Emde Abfangen und Vernichten von Viren und andere Mikroorganismen auf Oberflächen, in Raumluft, in der Abluft von Staubsaugern und in Raumluftfiltern.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145144A (en) * 1951-08-09 1964-08-18 Takeda Pharmacentical Ind Ltd Process for manufacturing chromium treated vaccines
FR1488212A (fr) * 1964-06-22 1967-07-13 Behringwerke Ag Procédé permettant d'atténuer le virus de la fièvre aphteuse
DE1253412B (de) * 1964-09-22 1967-11-02 Diamond Lab Inc Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
US3925544A (en) * 1971-07-12 1975-12-09 Univ Southern Illinois Bovine vaccines and methods of making and using same
US3907986A (en) * 1972-12-18 1975-09-23 Rit Rech Ind Therapeut Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
JPS5531762B2 (da) * 1973-03-28 1980-08-20
DE2860895D1 (en) * 1977-07-22 1981-11-05 Merck & Co Inc Parainfluenza virus vaccine and its preparation
JPS55104215A (en) * 1979-02-06 1980-08-09 Merck & Co Inc Parainfluenza virus vaccine and its manufacture
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines
IE66015B1 (en) * 1987-09-28 1995-11-29 Beecham Inc TGEV-virus of swine as a dog vaccine

Also Published As

Publication number Publication date
EP0310316A3 (en) 1990-02-14
GR3015608T3 (en) 1995-06-30
DE3886332T2 (de) 1994-03-31
PT88590A (pt) 1988-10-01
KR890004728A (ko) 1989-05-09
NZ226333A (en) 1991-09-25
ATE98680T1 (de) 1994-01-15
JPH01230523A (ja) 1989-09-14
EP0310316A2 (en) 1989-04-05
CA1331562C (en) 1994-08-23
CA1332919C (en) 1994-11-08
JPH01230532A (ja) 1989-09-14
JP2733844B2 (ja) 1998-03-30
EP0310316B1 (en) 1995-02-01
AU2281488A (en) 1989-04-06
JP2715114B2 (ja) 1998-02-18
IE60950B1 (en) 1994-09-07
DK175379B1 (da) 2004-09-20
IE882909L (en) 1989-03-28
AU624081B2 (en) 1992-06-04
ATE117899T1 (de) 1995-02-15
DK534188A (da) 1989-03-29
ES2061673T3 (es) 1994-12-16
DE3886332D1 (de) 1994-01-27
EP0310317B1 (en) 1993-12-15
IE882908L (en) 1989-03-28
AU2284388A (en) 1989-04-06
ZA887195B (en) 1989-07-26
ZA887196B (en) 1989-07-26
NZ226332A (en) 1991-10-25
PT88591A (pt) 1988-10-01
KR890004725A (ko) 1989-05-09
PT88591B (pt) 1992-11-30
EP0310317A3 (en) 1990-02-14
IE66015B1 (en) 1995-11-29
AU624339B2 (en) 1992-06-11
DK534288D0 (da) 1988-09-26
DE3852918T2 (de) 1995-07-13
KR0135426B1 (ko) 1998-04-23
EP0310317A2 (en) 1989-04-05
DE3852918D1 (de) 1995-03-16
ES2067474T3 (es) 1995-04-01
DK534288A (da) 1989-03-29
PT88590B (pt) 1993-04-30
DK175308B1 (da) 2004-08-16

Similar Documents

Publication Publication Date Title
DK534188D0 (da) Hidtil ukendt vaccine
DE69535530D1 (de) Impfstoff und Antitoxine zur Behandlung und Vorbeugung von C. Difficile Krankheiten
DE69433901D1 (de) Verbindungen und pharmazeutische zusammensetzungen zur behandlung und prophylaxe bakterieller infektionen
DE3684305D1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
IS5956A (is) Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
PT600396E (pt) Vacinas contra protozoarios intestinais
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
ITMI913493A1 (it) Dispositivo per la disinfezione o la immunizzazione di zone del corpo umano esposte al contagio, da germi, batteri e virus
BR9915533A (pt) Preparações de vacina contendo toxina atenuada
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
ES2138053T3 (es) Formulacion insecticida solida.
DE3785953T2 (de) Bakterientötende Gemische.
HUT71422A (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
DK15088D0 (da) Antibakterielt lyofiliseret praeparat
MX9400210A (es) Tratamiento de infecciones virales.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK